Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey

Abstract Introduction While various antiretrovirals have been studied as potential candidates for long‐acting pre‐exposure prophylaxis (PrEP), the bimonthly injectable cabotegravir—the first long‐acting form of PrEP—was approved in 2021. Event‐driven (ED) PrEP has been the most prevalent dosing regi...

Full description

Bibliographic Details
Main Authors: Jing‐Hao Hsu, Stephane Wen‐Wei Ku, Tsai‐Wei Chen, Chia‐Wen Li, Poyao Huang, Huei‐Jiuan Wu, Adam Bourne, Carol Strong
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of the International AIDS Society
Subjects:
Online Access:https://doi.org/10.1002/jia2.26163
_version_ 1797671651723182080
author Jing‐Hao Hsu
Stephane Wen‐Wei Ku
Tsai‐Wei Chen
Chia‐Wen Li
Poyao Huang
Huei‐Jiuan Wu
Adam Bourne
Carol Strong
author_facet Jing‐Hao Hsu
Stephane Wen‐Wei Ku
Tsai‐Wei Chen
Chia‐Wen Li
Poyao Huang
Huei‐Jiuan Wu
Adam Bourne
Carol Strong
author_sort Jing‐Hao Hsu
collection DOAJ
description Abstract Introduction While various antiretrovirals have been studied as potential candidates for long‐acting pre‐exposure prophylaxis (PrEP), the bimonthly injectable cabotegravir—the first long‐acting form of PrEP—was approved in 2021. Event‐driven (ED) PrEP has been the most prevalent dosing regimen among gay, bisexual and other men who have sex with men (GBMSM) in Taiwan, providing a unique setting to observe the preferences for long‐acting PrEP in a community where the daily regimen is not the mainstream method. This study aimed to determine the preferences for the different forms and dosing intervals of long‐acting PrEP that are currently in the development pipeline. Methods We conducted a survey in 2021 by convenience sampling the users of social networking applications for GBMSM in Taiwan. Our survey included questions on sexual behaviours, current PrEP regimens and the preferences for potential candidates of long‐acting PrEP, such as implants, intramuscular and subcutaneous injections. We compared the Likert‐scale preference ratings for potential long‐acting options, and conducted logistic regression analysis to examine the factors associated with a preference for bimonthly intramuscular injections (2M IM) over ED and daily PrEP regimens, respectively. Results A total of 1728 responses were eligible for analysis. Three percent of respondents (n = 52) were daily PrEP users; 11.5% (n = 198) were ED PrEP users. When not considering cost, current PrEP users—regardless of their original dosing regimen—were most likely to express preferences for monthly oral PrEP, followed by a 6‐month subcutaneous injectable (6M SC) and 2M IM. However, among non‐current PrEP users, monthly oral PrEP was the most preferred form, followed by ED, daily oral and 6M SC injectable. Multivariable logistic regression revealed that current daily users, those willing to take PrEP in the next 6 months and those with more sex partners in the last 12 months had a significant correlation with preferences for the 2M IM injectable over the ED PrEP. Conclusions The monthly oral form was the most preferable long‐acting PrEP among GBMSM in Taiwan. Current daily PrEP users preferred the 2M IM injectable over the ED PrEP, which made the 2M IM injectable a potential alternative. Further studies should focus on how the cost and delivery affect PrEP preferences and their actual uptake.
first_indexed 2024-03-11T21:18:38Z
format Article
id doaj.art-24f264fc45cf43d7b9d866430561d6f4
institution Directory Open Access Journal
issn 1758-2652
language English
last_indexed 2024-03-11T21:18:38Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Journal of the International AIDS Society
spelling doaj.art-24f264fc45cf43d7b9d866430561d6f42023-09-28T10:28:29ZengWileyJournal of the International AIDS Society1758-26522023-09-01269n/an/a10.1002/jia2.26163Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART SurveyJing‐Hao Hsu0Stephane Wen‐Wei Ku1Tsai‐Wei Chen2Chia‐Wen Li3Poyao Huang4Huei‐Jiuan Wu5Adam Bourne6Carol Strong7Department of Public Health College of Medicine National Cheng Kung University Tainan TaiwanDivision of Infectious Diseases Department of Medicine Taipei City Hospital Renai Branch Taipei TaiwanDepartment of Public Health College of Medicine National Cheng Kung University Tainan TaiwanInfection Control Center and Department of Internal MedicineNational Cheng Kung University HospitalCollege of MedicineNational Cheng Kung UniversityTainanTaiwanInstitute of Health Behaviors and Community Sciences National Taiwan University Taipei TaiwanThe Kirby InstituteUNSW SydneySydneyNew South WalesAustraliaThe Kirby InstituteUNSW SydneySydneyNew South WalesAustraliaDepartment of Public Health College of Medicine National Cheng Kung University Tainan TaiwanAbstract Introduction While various antiretrovirals have been studied as potential candidates for long‐acting pre‐exposure prophylaxis (PrEP), the bimonthly injectable cabotegravir—the first long‐acting form of PrEP—was approved in 2021. Event‐driven (ED) PrEP has been the most prevalent dosing regimen among gay, bisexual and other men who have sex with men (GBMSM) in Taiwan, providing a unique setting to observe the preferences for long‐acting PrEP in a community where the daily regimen is not the mainstream method. This study aimed to determine the preferences for the different forms and dosing intervals of long‐acting PrEP that are currently in the development pipeline. Methods We conducted a survey in 2021 by convenience sampling the users of social networking applications for GBMSM in Taiwan. Our survey included questions on sexual behaviours, current PrEP regimens and the preferences for potential candidates of long‐acting PrEP, such as implants, intramuscular and subcutaneous injections. We compared the Likert‐scale preference ratings for potential long‐acting options, and conducted logistic regression analysis to examine the factors associated with a preference for bimonthly intramuscular injections (2M IM) over ED and daily PrEP regimens, respectively. Results A total of 1728 responses were eligible for analysis. Three percent of respondents (n = 52) were daily PrEP users; 11.5% (n = 198) were ED PrEP users. When not considering cost, current PrEP users—regardless of their original dosing regimen—were most likely to express preferences for monthly oral PrEP, followed by a 6‐month subcutaneous injectable (6M SC) and 2M IM. However, among non‐current PrEP users, monthly oral PrEP was the most preferred form, followed by ED, daily oral and 6M SC injectable. Multivariable logistic regression revealed that current daily users, those willing to take PrEP in the next 6 months and those with more sex partners in the last 12 months had a significant correlation with preferences for the 2M IM injectable over the ED PrEP. Conclusions The monthly oral form was the most preferable long‐acting PrEP among GBMSM in Taiwan. Current daily PrEP users preferred the 2M IM injectable over the ED PrEP, which made the 2M IM injectable a potential alternative. Further studies should focus on how the cost and delivery affect PrEP preferences and their actual uptake.https://doi.org/10.1002/jia2.26163Asiagay, bisexual and other men who have sex with men (GBMSM)HIV preventionpolicypre‐exposure prophylaxis (PrEP)retention
spellingShingle Jing‐Hao Hsu
Stephane Wen‐Wei Ku
Tsai‐Wei Chen
Chia‐Wen Li
Poyao Huang
Huei‐Jiuan Wu
Adam Bourne
Carol Strong
Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
Journal of the International AIDS Society
Asia
gay, bisexual and other men who have sex with men (GBMSM)
HIV prevention
policy
pre‐exposure prophylaxis (PrEP)
retention
title Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
title_full Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
title_fullStr Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
title_full_unstemmed Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
title_short Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
title_sort preferences for long acting pre exposure prophylaxis among gay bisexual and other men who have sex with men in taiwan findings from the 2021 heart survey
topic Asia
gay, bisexual and other men who have sex with men (GBMSM)
HIV prevention
policy
pre‐exposure prophylaxis (PrEP)
retention
url https://doi.org/10.1002/jia2.26163
work_keys_str_mv AT jinghaohsu preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT stephanewenweiku preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT tsaiweichen preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT chiawenli preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT poyaohuang preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT hueijiuanwu preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT adambourne preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey
AT carolstrong preferencesforlongactingpreexposureprophylaxisamonggaybisexualandothermenwhohavesexwithmenintaiwanfindingsfromthe2021heartsurvey